Position in STTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,523,775
+$1,090,785 QoQ
Shares Held
392,500
-0.0% QoQ
Ownership
0.512%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $48,167,307,647 across 354 Biotechnology names. STTK ranks #178 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in STTK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,523,775 | 392,500 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,432,990 | 392,600 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,047 | 3,367 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,682 | 8,438 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,705 | 10,216 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $7,597 | 6,279 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $24,985,223 | 7,159,090 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,531,950 | 7,132,630 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $63,663,053 | 7,121,147 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $50,417,469 | 7,071,174 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,628,104 | 6,334,280 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $19,876,560 | 6,370,693 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $18,720,046 | 6,367,363 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $14,624,748 | 6,358,587 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,164,712 | 6,357,301 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $25,808,980 | 6,356,892 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $27,070,305 | 6,354,532 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $53,927,699 | 6,336,980 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $128,769,316 | 6,318,416 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $182,227,283 | 6,285,867 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $183,228,483 | 6,266,364 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $328,172,289 | 6,261,635 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||